CoChat

Radiotherapy equipment and departments in the European countries: Final results from the ESTRO-HERO survey

Open access
Grau, Cai, Defourny, Noémie, Malicki, Julian, Dunscombe, Peter, Borras, Josep M., Coffey, Mary, Slotman, Ben, Bogusz, Marta, Gasparotto, Chiara, Lievens, Yolande, Kokobobo, Arianit, Sedlmayer, Felix, Slobina, Elena, Feyen, Karen, Hadjieva, Tatiana, Odrazka, Karel, Eriksen, Jesper Grau, Jaal, Jana, Bly, Ritva, Chauvet, Bruno, Willich, Normann, Polgar, Csaba, Johannsson, Jakob, Cunningham, Moya, Magrini, Stefano, Atkocius, Vydmantas, Untereiner, Michel, Pirotta, Martin, Karadjinovic, Vanja, Levernes, Sverre, Skladowski, Krystof, Trigo, Maria Lurdes, Šegedin, Barbara, Rodriguez, Aurora, Lagerlund, Magnus, Pastoors, Bert, Hoskin, Peter, Vaarkamp, Jaap, Soler, Ramon Cleries · 2014 · Radiotherapy and Oncology
Cited by 178

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Documenting the distribution of radiotherapy departments and the availability of radiotherapy equipment in the European countries is an important part of HERO - the ESTRO Health Economics in Radiation Oncology project. HERO has the overall aim to develop a knowledge base of the provision of radiotherapy in Europe and build a model for health economic evaluation of radiation treatments at the European level. The aim of the current report is to describe the distribution of radiotherapy equipment in European countries. METHODS: An 84-item questionnaire was sent out to European countries, principally through their national societies. The current report includes a detailed analysis of radiotherapy departments and equipment (questionnaire items 26-29), analyzed in relation to the annual number of treatment courses and the socio-economic status of the countries. The analysis is based on validated responses from 28 of the 40 European countries defined by the European Cancer Observatory (ECO). RESULTS: A large variation between countries was found for most parameters studied. There were 2192 linear accelerators, 96 dedicated stereotactic machines, and 77 cobalt machines reported in the 27 countries where this information was available. A total of 12 countries had at least one cobalt machine in use. There was a median of 0.5 simulator per MV unit (range 0.3-1.5) and 1.4 (range 0.4-4.4) simulators per department. Of the 874 simulators, a total of 654 (75%) were capable of 3D imaging (CT-scanner or CBCT-option). The number of MV machines (cobalt, linear accelerators, and dedicated stereotactic machines) per million inhabitants ranged from 1.4 to 9.5 (median 5.3) and the average number of MV machines per department from 0.9 to 8.2 (median 2.6). The average number of treatment courses per year per MV machine varied from 262 to 1061 (median 419). While 69% of MV units were capable of IMRT only 49% were equipped for image guidance (IGRT). There was a clear relation between socio-economic status, as measured by GNI per capita, and availability of radiotherapy equipment in the countries. In many low income countries in Southern and Central-Eastern Europe there was very limited access to radiotherapy and especially to equipment for IMRT or IGRT. CONCLUSIONS: The European average number of MV machines per million inhabitants and per department is now better in line with QUARTS recommendations from 2005, but the survey also showed a significant heterogeneity in the access to modern radiotherapy equipment in Europe. High income countries especially in Northern-Western Europe are well-served with radiotherapy resources, other countries are facing important shortages of both equipment in general and especially machines capable of delivering high precision conformal treatments (IMRT, IGRT).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.radonc.2014.08.029

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 178

Metadata

Authors
Grau, C., Defourny, N., Malicki, J., Dunscombe, P., Borras, J. M., Coffey, M., Slotman, B., Bogusz, M., Gasparotto, C., Lievens, Y., Kokobobo, A., Sedlmayer, F., Slobina, E., Feyen, K., Hadjieva, T., Odrazka, K., Eriksen, J. G., Jaal, J., Bly, R., Chauvet, B., Willich, N., Polgar, C., Johannsson, J., Cunningham, M., Magrini, S., Atkocius, V., Untereiner, M., Pirotta, M., Karadjinovic, V., Levernes, S., Skladowski, K., Trigo, M. L., Šegedin, B., Rodriguez, A., Lagerlund, M., Pastoors, B., Hoskin, P., Vaarkamp, J., & Soler, R. C.
Venue
Radiotherapy and Oncology
Publisher
Elsevier BV
Published
2014-08
Volume
112
Issue
2
Pages
155-164
ISSN
0167-8140 (ISSN-L)
OpenAlex
W2112921409
Cited by
178
References
1
FWCI
13.47
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Radiotherapy equipment and departments in the European countries: Final results from the ESTRO-HERO survey. https://app.cochat.ai/papers/10.1016/j.radonc.2014.08.029
The paper
Grau, C., Defourny, N., Malicki, J., Dunscombe, P., Borras, J. M., Coffey, M., Slotman, B., Bogusz, M., Gasparotto, C., Lievens, Y., Kokobobo, A., Sedlmayer, F., Slobina, E., Feyen, K., Hadjieva, T., Odrazka, K., Eriksen, J. G., Jaal, J., Bly, R., . . . Soler, R. C. (2014). Radiotherapy equipment and departments in the European countries: Final results from the ESTRO-HERO survey. Radiotherapy and Oncology. https://doi.org/10.1016/j.radonc.2014.08.029

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.